+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anisindione"

From
Anisindione Market Analysis - Product Thumbnail Image

Anisindione Market Analysis

  • Report
  • October 2021
  • 142 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Anisindione is a hematological drug used to prevent and treat thromboembolic disorders, such as deep vein thrombosis and pulmonary embolism. It is an anticoagulant, meaning it works by inhibiting the body's ability to form blood clots. Anisindione is usually prescribed in combination with other anticoagulants, such as warfarin, to reduce the risk of clotting. It is available in both oral and injectable forms. Anisindione is used to treat a variety of conditions, including atrial fibrillation, stroke, and heart attack. It is also used to prevent blood clots in patients who have had surgery or are at risk for developing blood clots. Anisindione is generally well-tolerated, but it can cause side effects such as bleeding, dizziness, and nausea. The anisindione market is highly competitive, with several companies offering products. Some of the major players in the market include Pfizer, Merck, Bristol-Myers Squibb, and Sanofi. These companies offer a variety of products, including oral and injectable forms of anisindione. Show Less Read more